✦ LIBER ✦

A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report

Book ID: 122389531
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 163 KB
Volume: 6
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(90)90233-C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy confers modest

Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: Report of a Canadian Multicenter randomized trial

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 183 KB

P.19 Docetaxel compared with vinorelbine

P.19 Docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer (NSCLC): a preliminary report of a randomized phase III trial

✍ Karampeazis, A.; Vamvakas, L.; Tsiafaki, X.; Kalykaki, A.; Christophyllakis, Ch. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Randomized Phase II Trial of Onartuzumab

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Ervin, T. J.; Ramlau, R. A.; Daniel, D. B.; Goldschmidt, J. H.; B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB

Phase I trial of gemcitabine and cisplat

Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report

✍ Shepherd, Frances A.; Burkes, R.; Cormier, Y.; Crump, M.; Feld, R.; Strack, T. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 643 KB

Platinum-based combination chemotherapy

Platinum-based combination chemotherapy in advanced non-small cell lung cancer: A randomized phase II trial of the cancer and leukemia group B

✍ Green, Mark R. ;Kramar, Andrew ;Schilsky, Richard ;Stoopler, Marc ;Zimmer, Bonni 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract The Cancer and Leukemia Group B (CALGB) utilized a randomized phase II trial design to evaluate two cisplatin‐based combinations, cisplatin‐cytarabine (ara‐C) and cisplatin‐vinblastine, in 151 patients with advanced non‐small cell lung cancer. Patients entered on study had not received

Should chemotherapy combinations for adv

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials

✍ Pujol, Jean-Louis; Barlesi, Fabrice; Daurès, Jean-Pierre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB